These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18978296)

  • 21. Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies.
    Kanda J; Ichinohe T; Matsuo K; Benjamin RJ; Klumpp TR; Rozman P; Blumberg N; Mehta J; Sohn SK; Uchiyama T
    Transfusion; 2009 Apr; 49(4):624-35. PubMed ID: 19170998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature.
    Raimondi R; Soli M; Lamparelli T; Bacigalupo A; Arcese W; Belloni M; Rodeghiero F;
    Bone Marrow Transplant; 2004 Aug; 34(4):321-9. PubMed ID: 15235580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful management of sudden, massive immune hemolysis following ABO-incompatible allogeneic PBSCT despite methotrexate GvHD prophylaxis.
    Benson DM; O'Donnell L; Krugh D; Grady T; Blum W; Williams JD; Kennedy MS; Marcucci G
    Bone Marrow Transplant; 2005 Dec; 36(12):1111-2. PubMed ID: 16247426
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant human erythropoietin for long-term persistent anemia after major ABO-incompatible bone marrow transplantation.
    Taniguchi S; Yamasaki K; Shibuya T; Asayama R; Harada M; Niho Y
    Bone Marrow Transplant; 1993 Oct; 12(4):423. PubMed ID: 8275046
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study on Serological Blood Group Conversion in BM Empty Phase of ABO-incompatible Allogeneic Stem Cell Transplantation].
    Cai XJ; Chen BL; Xie ZT; Ye YC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):221-4. PubMed ID: 26913424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Major ABO incompatible bone marrow transplantation.
    Bacigalupo A; Avanzi G; Strada P; Adami R; Reali G; Barbanti M; Soldà A; Van Lint MT; Risso M; Rossi E; Cerri R; Vimercati R; Taroppio T; Spriano M; Brema F; Vitale V; Marmont A
    Haematologica; 1980 Apr; 65(2):211-21. PubMed ID: 6769762
    [No Abstract]   [Full Text] [Related]  

  • 27. Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility.
    Curtin NJ; Schwarer AP
    Clin Lab Haematol; 2005 Jun; 27(3):206-8. PubMed ID: 15938729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ABO-mismatched marrow transplantation: removal of mismatched donor red blood cells by "washing" with recipient's matched red blood cells in a closed system.
    Humpe A; Beck C; Claviez A; Riggert J
    Transfusion; 2005 Dec; 45(12):1985-7. PubMed ID: 16371056
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen.
    Peggs KS; Morris EC; Kottaridis PD; Geary J; Goldstone AH; Linch DC; Mackinnon S
    Blood; 2002 Jun; 99(12):4642-3; author reply 4643-4. PubMed ID: 12066785
    [No Abstract]   [Full Text] [Related]  

  • 31. [Extensive plasma exchange in ABO-incompatible bone marrow transplantation ].
    Osterwalder B; Gratwohl A; Bannert P; Müller M; Nissen C; Burri HP; Speck B
    Ther Umsch; 1982 Jul; 39(7):519-23. PubMed ID: 6750836
    [No Abstract]   [Full Text] [Related]  

  • 32. Rapid full engraftment and successful immune reconstitution after allogeneic hematopoietic stem cell transplantation with reduced intensity conditioning in Omenn syndrome.
    Gozdzik J; Czogala W; Skoczen S; Krasowska-Kwiecien A; Wiecha O; Mordel A; Lesko E; Majka M; Kowalczyk D; Zembala M
    Pediatr Transplant; 2009 Sep; 13(6):760-5. PubMed ID: 18992055
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation of major AB0-incompatible bone marrow: removal of red cells by dextrane sedimentation.
    Müller A; Hermann J; Fuchs D; Prager J; Burger E; Kob D; Goetz I; Zintl F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):475-9. PubMed ID: 2480293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rituximab for pure red cell aplasia after ABO-mismatched allogeneic peripheral blood progenitor cell transplantation.
    Sorà F; De Matteis S; Piccirillo N; Chiusolo P; Laurenti L; Putzulu R; Leone G; Sica S
    Transfusion; 2005 Apr; 45(4):643-5. PubMed ID: 15819690
    [No Abstract]   [Full Text] [Related]  

  • 35. Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation.
    Deotare UR; Vishwabandya A; Mathews V; George B; Srivastava A; Chandy M
    Bone Marrow Transplant; 2006 Jun; 37(12):1149-50. PubMed ID: 16699532
    [No Abstract]   [Full Text] [Related]  

  • 36. Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation.
    Worthley DL; Ruszkiewicz A; Davies R; Moore S; Nivison-Smith I; Bik To L; Browett P; Western R; Durrant S; So J; Young GP; Mullighan CG; Bardy PG; Michael MZ
    Stem Cells; 2009 Jun; 27(6):1463-8. PubMed ID: 19492298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful ABO-incompatible heart transplantation in a child despite blood-group sensitization after ventricular assist device support.
    Urschel S; Dalla Pozza R; Loeff M; Schmitz C; Sodian R; Schmoeckel M; Kowalski C; Netz H
    Pediatr Transplant; 2009 Sep; 13(6):773-6. PubMed ID: 19170929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Granulocyte transfusion for the treatment of prolonged pneumonia in a patient with MDS-RAEB-2 at allogeneic hematopoietic stem cell transplantation].
    Morita R; Hashino S; Takahashi S; Kanamori H; Onozawa M; Kahata K; Kondo T; Imamura M; Asaka M
    Rinsho Ketsueki; 2008 Feb; 49(2):89-93. PubMed ID: 18341038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation?
    Sheppard D; Huebsch LB; Bredeson C
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1760. PubMed ID: 24120381
    [No Abstract]   [Full Text] [Related]  

  • 40. Response to "What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation".
    Booth GS; Gehrie EA; Savani BN
    Biol Blood Marrow Transplant; 2013 Dec; 19(12):1760-1. PubMed ID: 24125949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.